Passage Bio Inc. Insider Trading
PASG
Insiders sold 113K and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. President and CEO William Chou sold 75K on Jan 8, 38% of their stake, outside a plan. The last open-market buy by an executive or director was in Mar 2022.
Get an email when PASG's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25 | Weston Nichols Large holder | Bought | 50,055 | $4.12 | 206K | 8.0% | Form 4 |
| Jan 8 | Kathleen Borthwick CFO | SoldNo plan | 2,062 | $18.44 | 38K | 28% | Form 4 |
| Jan 8 | William Chou President and CEO | SoldNo plan | 4,076 | $18.44 | 75K | 38% | Form 4 |
| Sep 11, 2025 – Sep 15, 2025 | Weston Nichols Large holder | Bought 3 parts | 32,008 | $6.99 average | 224K | 2.7% | Form 4 |
| Jul 22, 2025 – Jul 24, 2025 | Lynx1 Capital Management LP Large holder | Bought 3 parts | 128,848 | $5.69 average | 734K | 14% | Form 4 |
| Jun 24, 2025 – Jun 26, 2025 | Orbimed Advisors LLC Large holder | SoldNo plan 3 parts | 583,657 | $0.34 average | 197K | 8.8% | Form 4 |
| Apr 22, 2025 – Apr 24, 2025 | Orbimed Advisors LLC Large holder | SoldNo plan 3 parts | 235,572 | $0.33 average | 79K | 3.4% | Form 4 |
| Apr 15, 2025 – Apr 17, 2025 | Orbimed Capital GP VII LLC Large holder | SoldNo plan 3 parts | 149,054 | $0.33 average | 50K | 2.1% | Form 4 |
| Feb 11, 2025 | Kathleen Borthwick CFO | SoldNo plan | 3,183 | $0.53 | 2K | 7.2% | Form 4 |
| Jan 10, 2025 – Jan 14, 2025 | Orbimed Advisors LLC Large holder | SoldNo plan 3 parts | 223,219 | $0.64 average | 142K | 3.1% | Form 4 |
| Jan 6, 2025 – Jan 8, 2025 | Orbimed Capital GP VII LLC Large holder | SoldNo plan 3 parts | 147,024 | $0.70 average | 103K | 2.0% | Form 4 |
| Dec 27, 2024 | Lynx1 Capital Management LP Large holder | Bought | 373,645 | $0.65 | 243K | 4.2% | Form 4 |
| Dec 20, 2024 | Orbimed Capital GP VII LLC Large holder | SoldNo plan | 230,321 | $0.60 | 138K | 3.0% | Form 4 |
| Dec 9, 2024 – Dec 11, 2024 | Orbimed Advisors LLC Large holder | SoldNo plan 3 parts | 62,276 | $0.83 average | 52K | 0.8% | Form 4 |
| Dec 4, 2024 – Dec 6, 2024 | Orbimed Capital GP VII LLC Large holder | SoldNo plan 2 parts | 97,103 | $0.80 average | 77K | 1.2% | Form 4 |
| Nov 25, 2024 – Nov 27, 2024 | Lynx1 Capital Management LP Large holder | Bought 3 parts | 456,353 | $0.62 average | 284K | 2.7% | Form 4 |
- Jun 25Weston NicholsLarge holder · bought 50,055 at $4.12206K8.0% of stake
- Jan 8No planKathleen BorthwickCFO · sold 2,062 at $18.4438K28% of stake
- Jan 8No planWilliam ChouPresident and CEO · sold 4,076 at $18.4475K38% of stake
- Sep 11, 2025 – Sep 15, 2025Weston NicholsLarge holder · bought 32,008 at avg $6.99224K2.7% of stake
- Jul 22, 2025 – Jul 24, 2025Lynx1 Capital Management LPLarge holder · bought 128,848 at avg $5.69734K14% of stake
- Jun 24, 2025 – Jun 26, 2025No planOrbimed Advisors LLCLarge holder · sold 583,657 at avg $0.34197K8.8% of stake
- Apr 22, 2025 – Apr 24, 2025No planOrbimed Advisors LLCLarge holder · sold 235,572 at avg $0.3379K3.4% of stake
- Apr 15, 2025 – Apr 17, 2025No planOrbimed Capital GP VII LLCLarge holder · sold 149,054 at avg $0.3350K2.1% of stake
- Feb 11, 2025No planKathleen BorthwickCFO · sold 3,183 at $0.532K7.2% of stake
- Jan 10, 2025 – Jan 14, 2025No planOrbimed Advisors LLCLarge holder · sold 223,219 at avg $0.64142K3.1% of stake
- Jan 6, 2025 – Jan 8, 2025No planOrbimed Capital GP VII LLCLarge holder · sold 147,024 at avg $0.70103K2.0% of stake
- Dec 27, 2024Lynx1 Capital Management LPLarge holder · bought 373,645 at $0.65243K4.2% of stake
- Dec 20, 2024No planOrbimed Capital GP VII LLCLarge holder · sold 230,321 at $0.60138K3.0% of stake
- Dec 9, 2024 – Dec 11, 2024No planOrbimed Advisors LLCLarge holder · sold 62,276 at avg $0.8352K0.8% of stake
- Dec 4, 2024 – Dec 6, 2024No planOrbimed Capital GP VII LLCLarge holder · sold 97,103 at avg $0.8077K1.2% of stake
- Nov 25, 2024 – Nov 27, 2024Lynx1 Capital Management LPLarge holder · bought 456,353 at avg $0.62284K2.7% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with PASG
Spot a number that looks wrong? Check it in PASG's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PASG
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.